Theravie Pharma Form D (2026)
Theravie Pharma reported $750,000 raised in an SEC Form D filed on 2026-10-19.
- Company
- Theravie Pharma
- Round type
- Form D
- Date
- 2026-10-19
- Amount
- $750K
- Industry
- Biotechnology
- Location
- California
Summary
The SEC Form D for Theravie Pharma, filed on 2026-10-19, reports $750,000 raised. It was listed in the Raise Track Update of 2026-10-20. Filing: https://www.sec.gov/Archives/edgar/data/2160768/000216076826000001/0002160768-26-000001-index.htm
The form names Samia Lina Helena Almoughrabie and Richard Louis Gallo. This page uses Samia Almoughrabie and Richard Gallo, which are the names in the Raise Track Update.
This page is not indexed by search engines yet because the filing does not name the purchasers.
Investors
Sources
Last verified:
- https://www.sec.gov/Archives/edgar/data/2160768/000216076826000001/0002160768-26-000001-index.htm
Type: sec filing. Accessed 2026-10-20.
SEC Form D for Theravie Pharma, Inc.. EDGAR filing date 2026-10-19. Signed 2026-10-08. First sale 2026-09-29. Total amount sold $750,000 of an offering amount of $2,250,000. 1 investor already invested. Issuer address city is San Diego, California. Jurisdiction of incorporation is Delaware. Entity type on the form is Corporation. Year of incorporation on the form: 2025. The form does not name the purchasers or a round type. Street addresses are not published. The form describes the securities as equity and as a simple agreement for future equity (SAFE). The form names Samia Lina Helena Almoughrabie and Richard Louis Gallo. This page uses Samia Almoughrabie and Richard Gallo, which are the names in the Raise Track Update. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-20/
Type: other verified public source. Accessed 2026-10-20.
Raise Track Update for 2026-10-20, Section 3. Lists Theravie Pharma, state CALIFORNIA, industry Biotechnology, amount raised $750,000.